Capital Advisors Ltd’s Abiomed Inc ABMD Stock Holding History

Capital Advisors Ltd’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2	Closed	–	–	1779
2022 Q3	$0	Buy	+2	New	+$540	﹤0.01%	1641
2022 Q2	–	Sell	-1	Closed	–	–	1450
2022 Q1	$0	Hold	1	–	–	﹤0.01%	1310
2021 Q4	$0	Buy	+1	New	+$338	﹤0.01%	978

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Capital Advisors Ltd's ABMD Position: Q4 2022 in Review

Capital Advisors Ltd sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2 shares.

Capital Advisors Ltd first reported a position in ABMD in Q4 2021 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Capital Advisors Ltd reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Capital Advisors Ltd sold 2 Abiomed Inc shares in Q4 2022.
Capital Advisors Ltd first reported a position in Abiomed Inc in Q4 2021 and held it in 3 quarters.
Capital Advisors Ltd's Abiomed Inc position peaked at $0 in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Capital Advisors Ltd's 13F filing for Q4 2022, filed 7 Feb 2023.